Related Experiment Video
Updated: Sep 26, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
[Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy]
1Service de Cardiologie, Centre Hospitalier Régional Hutois.
Abstract:
We report the case of a 48-year-old woman who present a tricuspid, mitral and aortic regurgitation after long term ingestion of ergot alkaloids. Tricuspid and mitral fibrosis associated with retraction of the aortic leaflets are the causes of heart failure. Replacement of the three valves will be necessary. This is one, not the least complication of long-term ergotamine therapy.
Related Concept Videos
Mitral Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
